Blood Plasma Derivatives Market Research Report - Forecast till 2030

Blood Plasma Derivatives Market Research Report Information Information by Type [Factor VIII Concentrate, Factor IX Concentrate, Albumin, Immune Globulins, Anti-Thrombin III Concentrate, and Fresh Frozen Plasma (FFP)], Application (HIV, Hemophilia A, Hemophilia B, Hepatitis B, Hepatitis C, Bleeding Disorders, Hypogammaglobulinemia, Immunodeficiency Diseases, and Others), End User (Hospitals & Clinics, Blood Transfusion Centers, Diagnostic Centers, and Others), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast ti

ID: MRFR/Pharma/0817-HCR | 80 Pages | Author: Rahul Gotadki | May 2023         

Blood Plasma Derivatives Market Speak to Analyst Request a Free Sample

Blood Plasma Derivatives Market Overview

The blood plasma derivatives market is expected to reach USD 40, 475.8 Million by 2030 at 10.50% CAGR during the forecast period 2022-2030. The Blood Plasma Derivatives Market is becoming essential because of the expanding interest for plasma inferred items. As indicated by a new market, The Blood Plasma Derivatives Industry is enhancing its growth and is expected to acquire noticeable quality over the estimated period.

You must know that Plasma is a liquid piece of the blood that contains platelets and protein answerable for blood thickening. Plasma Derivatives are obtained from explicit plasma proteins by the cycle of fractionation. The Derivatives are then dissolvable cleansers treated or heat-treated to kill certain infections. The most widely recognized plasma subsidiary mainly includes factor IX concentrate, hostile to inhibitor coagulation complex (AICC), factor VIII concentrate, against thrombin III concentrate, Alpha 1-Proteinase inhibitor concentrate, insusceptible globulins, egg whites, and against thrombin III concentrates. Blood plasma derivatives 3 are broadly utilized clinically to treat different conditions, such as HIV, thrombocytosis, hemophilia A, hemophilia B, hepatitis B, hepatitis C, etc. 

Rising interest in plasma derivatives-based treatments is the key factor driving the blood plasma derivatives market. As per an investigation distributed in the Journal of Plasma Medicine in 2016, it is discovered that FIX substitution treatment, which incorporates plasma-inferred protein, is fruitful in the decrease of incapacity and draining from hemophilia B. Based on the commonness rate, hemophilia and von Willebrand sickness (VWD) are the most widely recognized draining problems in the Middle East & Africa. In recent times the blood plasma derivatives market demand is increasing due to the effective use of plasma in medical treatment. 

Covid-19 Analysis

The COVID-19, which started in China, has now transformed into a pandemic due to the increasing numbers of cases all over the globe. More than two nations are confronting the difficult undertaking of battling this deadly infection. There has been some topsy-turvy dissemination with regards to the increasing number of patients and death rate. The medical services industry, then again, is anticipated to display some acceleration in the market development attributable to the flood in the prerequisites of clinical fundamentals like PPE units, advanced x-beam machines, ventilators, and much more. There has been a critical flood in the examination exercises for creating suitable medications to fix this infection or stop the transmission chain. More than 75 antibody applicants and more than 120 remedial competitors are being thought of and are being tried on different levels. 

Blood plasma derivatives market analysis has witnessed a rise in the demand for the plasma due to the spread of this covid-19 infection. It was observed that this deadly infection could be treated through plasma treatment. 

Regional Market Summary Global Blood Plasma Derivatives Market Share, by Region, 2018 (%) Blood Plasma Derivatives Market Share

Source: World Health Organization (WHO)

Market Dynamics


Expanding thrombocytosis rates are considered a significant driver for the development of the Global blood plasma derivatives market. The National Institutes of Health (NIH) and Community for Disease Control (CDC) conduct mindfulness programs for forestalled thrombocytosis and related difficulties. Global Blood Plasma Derivatives Industry was about is relied upon to arrive at US$ 30.5 billion by 2023 at a CAGR of 7.52% during estimated period 2017 to 2023. This driver is effectively driving the growth of the blood plasma derivatives market in the forecasted period. 


The singular market affecting variables and changes in the guideline in the market is locally impacting the current and future patterns of blood plasma derivatives market. The information focuses on utilization volumes, creation destinations and volumes, cost of crude materials, import send out examination, value pattern investigation, downstream and upstream worth chain examination, which is a portion of the significant pointers used to handle the market situation for singular nations. Additionally, the presence and accessibility of worldwide brands and their challenges are affecting the growth of the neighborhood and local brands. It also affects local duties, and shipping lanes are thought of while investigating the nation's information. These challenges are restricting the growth of the blood plasma derivatives market. 


Expanding the selection of blood plasma derivatives items, developing an effective populace, and expanding mindfulness about blood and plasma gifts will probably speed up the development of the blood plasma derivatives market in the figure time of 2020-2027. Then again, developing the expense of plasma derivatives-based treatment will also support different freedoms that will prompt the development of the animal blood plasma products and derivatives market in the estimated time frame.


A post-usable danger related to plasma derivatives treatment will probably hamper the development of the plasma products and derivatives market in the forecasted time frame.

Cumulative growth Analysis

Blood plasma derivatives have a wide scope of clinical applications. These are utilized in the treatment of different perilous sicknesses. Blood plasma derivatives are gotten from blood givers. Headway and improvement of better strategies for conserving these blood plasma derivatives alongside fresher and created methods for fractionation fuel the development of the Global blood plasma derivatives market. Additionally, rising instances of dangerous sicknesses like hepatitis, HIV, and hemophilia provoke interest and opportunity in the global blood plasma derivatives market. Besides, different government and non-administrative associations' drives to direct and advance blood gift camps have expanded human blood assortment. This is boosting the development of the blood plasma derivatives industry. 

Blood Plasma Derivatives Market Segment Overview

By Type

Based on type, the blood plasma derivatives market is effectively segmented into egg whites, immunoglobulin, factor VIII, factor IX, hyperimmune globulin, and much more. The immunoglobulin section represented the biggest portion of the overall industry and is required to proceed with this pattern all through the estimated period. Then again, the egg whites portion is expected to develop at a huge CAGR of 9.4% during the figure time frame. 

By Application

Based on application, the blood plasma derivatives market is divided into hemophilia, immunodeficiency infections, hypogammaglobulinemia, von Willebrand's Disease (vWD), and different applications. The immunodeficiency illnesses portion represented the biggest part. 

By End-User

Based on end-user, the blood plasma derivatives market is divided into medical centers, clinics, and opposite end users. Medical clinics held the biggest portion of the market, while the center's section is relied upon to enroll the most noteworthy development rate during the estimated time frame. 

By Region

Based on region, the blood plasma derivatives market is segmented as Asia-Pacific, North America, Europe, and LAMEA. North America held the biggest portion of the market, trailed by Europe. Then again, Asia-Pacific is expected to overwhelm the market during the investigation time frame, attributable to the high populace base, expansion in extra cash, and improvement in understanding mindfulness about plasma subsidiaries. In addition, Asia is an enormous mainland and has arisen as a focal point of perilous sicknesses.

Blood Plasma Derivatives Market Regional Analysis 

The blood plasma derivatives market comprises four areas Asia-Pacific North America, Europe, & Middle East, and Africa. North America is mainly segmented into nations, in particular the U.S., Canada & Mexico. Europe market comprises of nations specifically U.K. Italy, France, Germany, Spain and Rest of Europe. The Asia-Pacific market comprises of nations specifically Australia, India, China, Japan, Republic of Korea and Rest of Asia-Pacific and the Middle East and Africa comprises of nations, in particular, United Arab Emirates, Turkey, Saudi Arabia, and Rest of Middle East & Africa. North America is required to be the biggest market for blood plasma derivatives. Expansion in mindfulness with respect to occurrences of thrombocytosis and utilization of plasma derivatives to kill infections causing irresistible illnesses to favor the development of the market around here. Interest for innovative headway in plasma inferred items and broad exploration underway of plasma subordinates start the development of this market in Europe. Asia-Pacific is required to show the quickest development in view of expansion in the pervasiveness of irresistible illnesses and accentuation on safe blood bonding methodology. Nations in Middle East & Africa, for the most part, send out plasma got items from the North American & European nations.

Blood Plasma Derivatives Market Major Market Players

The key players of the Global blood plasma derivatives market:

  • Grigols (Spain)

  • SK Plasma Co., Ltd. (South Korea)

  • Bain Capital, LLC (US)

  • Biotest AG (Germany)

  • Baxter International Inc. (US)

  • Octapharma AG (Switzerland)

  • CSL Limited (Australia)

  • Kedrion S.p.A (Italy)

  • Fusion Healthcare (India)

Recent Developments

  • In March 2020, Grifols, S.A., declared a coordinated effort with US Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA).

Report Overview

  • Market overview highlights the global recognition of blood plasma derivatives market insights overview

  • Analysis based upon COVID 19

  • Explanation upon the Blood Plasma Derivatives Market  Dynamics

  • Value chain analysis for the blood plasma derivatives market size Report.

  • Market segmentation overview

  • The regional analysis of blood plasma derivatives industry overview

  • Competitive landscape analysis

  • Recent Developments of bovine blood plasma derivatives market Forecast

The report highlights the global blood plasma derivatives market development includes its revenue hike's growth potential by the end of the forecast years in 2028.

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 40, 475.8 Million
  CAGR   10.50%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Baxter BioScience, Grifols S.A., CSL Behring, ViroPharma, Inc., Talecris Biotherapeutics, Inc., Octapharma, Fusion Healthcare, SK Plasma Co., Ltd., Biotest AG, Green Cross Corporation, and Shire Plc.
  Key Market Opportunities   safety concerns during blood transfusion
  Key Market Drivers

  • rising incidences of infectious diseases
  • growing demand for plasma derivatives to treat life-threatening disorders

  • Frequently Asked Questions (FAQ) :

    The Involved End Users Are Diagnostic Centers, Blood Transfusion Centers, Hospitals & Clinics, And Others.

    The Immune Globulins Segment To Lead The Market.

    The Immunodeficiency Segment Would Head The Market.

    Key Questions Answered

    • ✅ Global Market Outlook
    • ✅ In-depth analysis of global and regional trends
    • ✅ Analyze and identify the major players in the market, their market share, key developments, etc.
    • ✅ To understand the capability of the major players based on products offered, financials, and strategies.
    • ✅ Identify disrupting products, companies, and trends.
    • ✅ To identify opportunities in the market.
    • ✅ Analyze the key challenges in the market.
    • ✅ Analyze the regional penetration of players, products, and services in the market.
    • ✅ Comparison of major players’ financial performance.
    • ✅ Evaluate strategies adopted by major players.
    • ✅ Recommendations
    Request Free Sample

    Why Choose Market Research Future?

    • ✅ Vigorous research methodologies for specific market.
    • ✅ Knowledge partners across the globe
    • ✅ Large network of partner consultants.
    • ✅ Ever-increasing/ Escalating data base with quarterly monitoring of various markets
    • ✅ Trusted by fortune 500 companies/startups/universities/organizations
    • ✅ Large database of 5000+ markets reports.
    • ✅ Effective and prompt pre- and post-sales support.
    Speak to Analyst
    Leading companies partner with us for data-driven Insights.
    Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

    Kindly complete the form below to receive a free sample of this Report

    Please fill in Business Email for Quick Response